Integrated in silico analysis of LRP2 mutations to immunotherapy efficacy in pan-cancer cohort
Abstract Purpose Immunotherapy has emerged as a novel therapy, while many patients are refractory. Although, several biomarkers have been identified as predictive biomarkers for immunotherapy, such as tumor specific genes, PD-1/PD-L1, tumor mutation burn (TMB), and microsatellite instability (MSI),...
Shranjeno v:
| Principais autores: | , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Springer
2022-07-01
|
| Serija: | Discover Oncology |
| Teme: | |
| Online dostop: | https://doi.org/10.1007/s12672-022-00528-8 |
| Oznake: |
Brez oznak, prvi označite!
|